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ABSTRACT
Stress-induced angiogenin (ANG)-mediated tRNA
cleavage promotes a cascade of cellular events
that starts with production of tRNA-derived stress-
induced RNAs (tiRNAs) and culminates with en-
hanced cell survival. This stress response pro-
gram relies on a subset tiRNAs that inhibit trans-
lation initiation and induce the assembly of stress
granules (SGs), cytoplasmic ribonucleoprotein com-
plexes with cytoprotective and pro-survival proper-
ties. SG-promoting tiRNAs bear oligoguanine motifs
at their 5′-ends, assemble G-quadruplex-like struc-
tures and interact with the translational silencer
YB-1. We used CRISPR/Cas9-based genetic manip-
ulations and biochemical approaches to examine
the role of YB-1 in tiRNA-mediated translational re-
pression and SG assembly. We found that YB-1 di-
rectly binds to tiRNAs via its cold shock domain.
This interaction is required for packaging of tiRNA-
repressed mRNAs into SGs but is dispensable for
tiRNA-mediated translational repression. Our stud-
ies reveal the functional role of YB-1 in the ANG-
mediated stress response program.
INTRODUCTION
Unfavorable environments trigger several stress response
programs that promote the repair of stress-induced dam-
age and enhance cell survival. Because protein synthesis is
an energy-intensive process, inhibition of mRNA transla-
tion is a major component of these programs (1). Phos-
phorylation of eIF2 by any one of four stress responsive
kinases (e.g. PERK, PKR, GCN4 or HRI) is the primary
mechanism through which cells regulate global translation.
Phosphorylation of Ser-51 of eIF2 inhibits GDP:GTP ex-
change by eIF2B, thereby blocking translation initiation
(2). Translationally stalled ribonucleoprotein (RNP) com-
plexes are organized into discrete cytoplasmic foci known
as Stress Granules (SGs). In addition to conserving an-
abolic energy by preventing the synthesis of housekeeping
proteins, SGs promote cell survival by sequestering pro-
apoptotic signalling proteins (e.g. RACK1 and TRAF2)
and promoting the translation of a select group of mR-
NAs harboring upstream open reading frames (uORFs) or
internal ribosome entry sites (IRESes) (3). Translation of
stress-activated IRES-containing mRNAs, such as BCL-2,
or uORF-containing mRNAs such as ATF4, contributes to
the survival of cells exposed to adverse environmental con-
ditions (4).
Phospho-eIF2 independent triggers of SG assembly in-
clude eIF4A inhibitors (5) and hypertonic stress (6). We
have discovered that stress-induced tRNA cleavage also
triggers phospho-eIF2 independent SG assembly (7–9). In
response to specific environmental stresses, a small percent-
age of tRNA (∼1%) is cleaved within anti-codon loops by
angiogenin (ANG), a stress-activated ribonuclease (RNase)
(8,10,11). tRNA cleavage produces two small non-coding
(nc)RNAs that we have termed 5′- and 3′-tRNA derived
stress-induced RNAs (5′- or 3′-tiRNAs) (8). In our initial
analysis of tiRNA bioactivity, we discovered that a sub-
set of 5′-tiRNAs, but not 3′-tiRNAs, inhibits global trans-
lation. Inhibition of mRNA translation is not sequence-
dependent as it does not rely on RNA:RNA base pairing
as with miRNA-mediated inhibition. These bioactive 5′-
tiRNAs inhibit translation initiation by displacing eIF4F
from the m7GTP cap of mRNAs, thereby inhibiting cap-
dependent translation and triggering the phospho-eIF2
independent assembly of SGs (9). The ability of bioactive
5′-tiRNAs to displace eIF4F from mRNAs is dependent
upon a 5′-terminal oligoguanine (5′-TOG) motif that folds
into G-quadruplex-like structures (9,12). Two 5′-tiRNAs,
5′-tiRNAAla and 5′-tiRNACys, contain this motif and are
able to inhibit translation and trigger the formation of SGs.
ANG treatment, which induces the production of endoge-
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nous tiRNAs, or transfection with exogenous DNA ana-
logues of 5′-TOG-containing tiRNAs, promotes the sur-
vival of motor neurons in response to excitotoxic or serum
withdrawal associated stresses (12).
RNA affinity chromatography followed by mass spec-
troscopy identified the multifunctional cold-shock domain
(CSD)-containing Y-box binding protein 1 (YB-1, YBX1)
as a component of the 5′-TOG-tiRNA RNP (9). CSD-
containing proteins bind both DNA and RNA and are in-
volved in diverse RNAmetabolism pathways. Examples in-
clude Lin28 which regulates pre-let7 miRNA biogenesis,
and Upstream of N-Ras (UNR/CSDE1) which regulates
mRNA translation and stability (13). The YB-1 CSD binds
5′-tiRNA in a sequence specific manner. YB-1 also pos-
sesses an oligomerization domain (OMD) that binds RNA
in a sequence non-specific manner. Whereas a single YB-1
polypeptide is ∼35 kDa, the OMD promotes the assembly
of 800–1000 kDa aggregates (14). Similar to other CSDpro-
teins, YB-1 is an established regulator of translation. At low
concentrations, YB-1 is thought to promote the translation
of mRNAs to which it is bound, but at higher concentra-
tions, it inhibits translation (15). This activity is likely due to
the ability of YB-1 to dissociate eIF4G from mRNAs (16).
YB-1 has been implicated in many pathological states;
notably, it is highly expressed in many cancers and its
expression is positively correlated with increased metas-
tasis and survival (17–19). This is likely due to its abil-
ity to promote an epithelial-to-mesenchymal transition
(EMT), a dedifferentiated state that promotes cellmigration
and metastasis (20,21). YB-1 overexpression in epithelial
MCF10AT cells bestows mesenchymal-like properties in-
cluding increased invasion through soft agar, disruption of
round, ordered acini structures in 3D culture and alteration
of gene expression. These changes are accompanied by in-
creased expression of EMT-associated transcription factors
such as Twist1 and Snail1 (18,21). In its cytoplasmic role,
YB-1 is a component of SGs and it has been reported to
promote SG assembly in a G3BP1-dependent manner (22).
Precisely how 5′-TOG-containing tiRNAs displace
eIF4F and promote SG assembly is unknown. Here, we
investigate the role that YB-1 plays in tiRNA-mediated
translational control. Using YB-1 knockout cells generated
by CRISPR/Cas9, we show that YB-1 is required for
SG formation in response to 5′-TOG-containing tiRNAs.
This activity is dependent upon YB-1 binding to 5′-TOG-
containing tiRNAs though it’s CSD. In contrast, YB-1 is
dispensable for tiRNA-mediated eIF4F displacement and
translation inhibition. This work identifies the step at which
YB-1 functions in the tiRNA pathway. We also describe a
YB-1 frameshift mutation found in several cancer cell lines
whose independent selection suggests a possible role in the
cancer phenotype.
MATERIALS AND METHODS
Antibodies
The following antibodies were used for Western blot-
ting and immunofluorescence: YB-1 (Abcam: Ab12148,
Proteintech Group: 20339-1-AP, Bethyl Laboratories,
Inc (A): A404-230-T, Bethyl Laboratories, Inc (B):
A303-231-T), Dach1 (Proteintech Group: 10914-1-AP),
Caprin1 (Proteintech Group: 14112-1-AP), G3BP1 (Santa
Cruz Biotechnology, Inc: sc-81940), G3BP2 (Bethyl Lab-
oratories, Inc: A302-040A), TIA-1 (Santa Cruz Biotech-
nology, Inc: sc-1751), TIAR (Santa Cruz Biotechnol-
ogy, Inc: sc-1749), eIF3b (Santa Cruz Biotechnology,
Inc: sc-16377), eIF4G (Santa Cruz Biotechnology,
Inc: sc-11373), eIF4E-BP1 (Cell Signaling Technol-
ogy: 9452S), PABP (Santa Cruz Biotechnology, Inc:
sc-32318), Nucleolin (Santa Cruz Biotechnology, Inc:
sc-9893), eIF4E (Santa Cruz Biotechnology, Inc: sc-
9976), HuR (Santa Cruz Biotechnology, Inc: sc-5261),
Fxr2 (Santa Cruz Biotechnology, Inc: sc32266), Rack1
(Santa Cruz Biotechnology, Inc: sc-17754), RPS23 (Santa
Cruz Biotechnology, Inc: sc-100837), Twist1 (Bethyl Lab-
oratories, Inc: A301-394A), Snail1 (Origene: TA500416),
Zeb1 (Bethyl Laboratories, Inc: A301-921A), Puromycin
(EMD Milipore: 12D10), GFP (Applied Biological
Materials: G160), -actin (Proteintech Group: 66009-1).
CRISPR/Cas9 mediated knockout of YB-1
Oligonucleotides encoding gRNAs targeting the first exon
of YB-1 were designed using CRISPR Design software
from the Zhang lab (crispr.mit.edu). Oligonucleotides were
annealed and cloned into pCas-Guide (Origene) accord-
ing to manufacturer’s protocol. gRNAs target the follow-
ing sequences within YB-1: gRNA1, AGCGCCGCCGAC
ACCAAGCC; gRNA2, CGACACCAAGCCCGGCAC
TA; gRNA3, GACACCAAGCCCGGCACTAC; gRNA4,
AAGCCCGGCACTACGGGCAG. pCas-guide plasmids
with cloned with gRNAs were transfected into U2OS or
MCF7 cells using Lipofectamine 2000 (Invitrogen). Cells
were allowed to recover for seven days and then immunos-
tained for YB-1 to determine the percentage of knockouts.
MCF7 cells were first ‘pool cloned’ to enrich knockouts by
plating 5–10 cells perwell in a 24-well plate. Pool cloneswere
screened by immunofluorescence. Pool cloned MCF7 cells
and original transfection of U2OS were cloned by limiting
dilution and screened by immunofluorescence and Western
blotting.
siRNA knockdown
U2OS cells (100 000 cells/well) were seeded in 6-well plates
and grown for 24 h. The first round of siRNA transfection
was using 100 pmol siRNA (SmartPool, Dharmacon), 2.5
l Lipofectamine 2000 (Invitrogen) in OPTI-MEM (Life
Technologies). The second transfection was done 48 h later
with the same conditions as the first one.
Genotyping of YB-1
Cells were resuspended at 108 cells/ml in digestion buffer
(100 mM NaCl, 10 mM TRIS [pH 8.0], 25 mM EDTA
[pH 8.0], 0.5% SDS, 0.1 mg/ml proteinase K) and in-
cubated overnight at 55◦C. DNA was extracted with
phenol/chloroform and precipitated with ammonium ac-
etate and 2 volumes of 100% ethanol, washed with 70%
ethanol and air dried. DNA pellet was resuspended in
TE buffer containing 0.1% SDS and RNase A (1 g/ml)
and incubated at 37◦C for 1 h. DNA was extracted with
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phenol/chloroform and precipitated as described above.
Resulting pellet was resuspended at a concentration of 100
ng/l.
For genotyping, the first exon of YB-1 was ampli-
fied by polymerase chain reaction (PCR) using primers
located within the promoter and first intron (Forward:
GGTCCAATGAGAATGGAGGA,Reverse: AGCTCCG-
GCTAACGGTTC) using AccuprimeG–C rich polymerase
(Invitrogen). Amplicons were sequenced directly or cloned
into pGEM–T Easy vector (Promega) and sequenced indi-
vidually.
Stress granule induction and quantification
Stress granules were induced using sodium arsenite or thap-
sigargin at indicated concentrations for 1 h. Alternatively,
cells were transfected with 250 pmol of indicated RNA for
6 h using Lipofectamine 2000 (Invitrogen). Cells were man-
ually scored for SGs using fluorescence microscopy with
eIF4G, TIAR and G3BP1 as SG markers (23). Only cells
with granules co-staining for all three markers were consid-
ered SGs, and a minimum of 3 SGs per cell were required
to score positive.
Immunofluorescence
Cells were fixed and processed for fluorescence microscopy
as described previously (23). Briefly, cells were grown on
glass coverslips, stressed as indicated and fixed with 4%
paraformaldehyde in PBS (phosphate buffered saline) for
15 min followed by 10 min post-fixation/permeabilization
in −20◦C methanol. Cells were blocked for 1 h in 5% horse
serum/PBS. Primary and secondary antibody incubations
were performed in blocking buffer for 1 h with rocking
at room temperature. Secondary antibodies (Jackson Lab-
oratories) were tagged with Cy2, Cy3 or Cy5. Following
washes with PBS, cells were mounted in polyvinyl mount-
ing media and viewed at room temperature using a Nikon
Eclipse E800microscopewith a 40XPlan fluor (NA0.75) or
100XPlanApo objective lens (NA1.4) and illuminatedwith
a mercury lamp and standard filters for DAPI (UV-2A -
360/40; 420/LP), Cy2 (FITCHQ 480/40; 535/50), Cy3 (Cy
3HQ 545/30; 610/75) and Cy5 (Cy 5 HQ 620/60; 700/75).
Images were captured with SPOT Persuit digital camera
(Diagnostic Instruments) with the manufacturers software
and compiled using Adobe Photoshop CC 2015.
m7GTP binding assay
eIF4F was assembled onto m7GTP-agarose (Jena Bio-
science) as previously described (9). Assembled eIF4F com-
plexes were challenged with 100 pmol of indicated RNA for
2 h at 4◦C while tumbling. Displaced proteins were washed
away with NP-40 lysis buffer (10 mMTris [pH 8.0], 100 mM
NaCl, 0.5%NP-40, 1 mMEDTA) and bound proteins were
eluted with 60 l of 1X SDS-Loading dye. eIF4F displace-
ment was assessed by analyzing eIF4G and eIF4E by west-
ern blotting.
Cloning and purification of recombinant YB-1
Human YB-1 was amplified from human cDNA pre-
pared using Superscript III (Invitrogen) according to man-
ufacturer’s instructions and cloned into pET42 between
BamHI and XhoI using the following DNA oligonu-
cleotides: ttttggatccATGAGCAGCGAGGCCGAG (for-
ward) and ttttctcgagTTACTCAGCCCCGCCCTG (re-
verse). The YB-1 (1-129) fragment was subcloned into
pET42 between BamHI and XhoI using the follow-
ing oligonucleotides: ttttggatccATGAGCAGCGAGGCC-
GAG (forward) and ttttctcgagttaACCAGGACCTGTAA-
CATTTG (reverse). For F85A mutation, overlap PCR was
used (24). Resulting mutated amplicons were cloned into
pET42 between BamHI and XhoI. All vectors were con-
firmed by DNA sequencing.
For protein expression, BL21(DE3) E. coli were trans-
formed with either pET42-YB1 (1-129) or pET42-YB1
(1-129)-F85A. Individual clones were picked and grown
overnight. The following day 500 ml cultures were inocu-
lated with 25ml of overnight culture and grown until OD600
= 0.4–0.6. Cultures were induced with 0.5 mM IPTG for 4 h
and harvested by centrifugation. His-taggedYB-1 was puri-
fied using Ni-NTA agarose (Qiagen) using non-denaturing
conditions according to manufacturer’s instructions.
Electrophoretic mobility shift assay (EMSA)
Electrophoretic mobility shift assays (EMSA) were per-
formed as previously described (25). RNA was end-labeled
with  -32P-ATP (Perkin Elmer) using T4 PNK followed by
purification through G-25 Sephadex. For each shift, 0.25
pmol of RNA was used. The RNA was incubated on ice
with various amounts of purified recombinant protein in
10 mM HEPES [pH 7.6], 50 mM KCl, 0.1 mM EDTA,
10%glycerol, 0.5g yeast tRNA, 0.1g/l BSA.Reactions
were loaded directly onto native polyacrylamide gel (acry-
lamide:bisacrylamide 29:1 in 1X TBE/5% glycerol). The ra-
dioactive complexes were visualized by autoradiography.
In vitro translation assay
U2OS cells were grown in 100 mm dishes until ∼75%
confluent. Cells were removed from dish by trypsiniza-
tion, washed in DMEM containing 10% fetal bovine serum
(FBS) to neutralize trypsin. Cells were washed two times
in HBSS to remove DMEM. Cells were diluted to 8 × 107
cells/ml in Lysolecitin buffer (20 mM HEPES-KOH [pH
7.4], 100 mM KOAc, 2.2 mM Mg(OAc)2, 2 mM DTT, 0.1
mg/ml lysolecitin) and incubated on ice for 1 min. Cells
were pelleted by centrifugation for 10 s at 10000 xg. Super-
natant was discarded and cells were resuspended in 0.5 ml
of hypotonic extraction buffer (20 mM HEPES-KOH [pH
7.4], 10 mMKOAc, 1 mMMg(OAc)2, 4 mMDTT, 1X pro-
tease inhibitor (Thermo Scientific) and incubated on ice for
5 min. Cells were disrupted by passage through a 27-gauge
needle 10 times. Cell debris was pelleted for 10 min by cen-
trifugation at 10000 xg. Supernatant was removed to new
tube, aliquoted, quick frozen on dry ice and stored at−80◦C
until needed.
The plasmid phRL-5BoxB (encoding luciferase mRNA
reporter) was linearized with XhoI; Renilla luciferase
RNA was transcribed using T7 RiboMax Express Large
Scale RNA Production System (Promega). RNA was
phenol/chloroform extracted, precipitated with ammo-
nium acetate, resuspended in ddH2O and further purified
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by removing unincorporated nucleotides by G-25 Sephadex
size exclusion chromatography. Resulting RNAwas diluted
to 100 ng/l.
Translation reactions were carried out as previously de-
scribed (26). For in vitro translation reactions, 1 l of Re-
nilla luciferase mRNA reporter (100 ng/l), 4 l of trans-
lation extract, 0.2 l of RNasin (Promega), 2 l of 5X
Translation buffer (100 mM HEPES-KOH [pH 7.6], 5 mM
DTT, 2.5 mM Spermidine-HCl, 3 mMMg(CH3COO)2, 40
mM creatine phosphate, 5 mM ATP, 1 mM GTP, 600 mM
KCH3COO, 125 M amino acids) and 1 l of indicated
controlRNA (three unrelated controlRNAswe used: Ctrl1,
Ctrl2 andD0R0; all 100M)or 5′-tiRNAAla (100M)were
mixed and brought to 10 l with ddH2O. Reactions were
incubated at 30◦C for 1 h. Luciferase activity was assayed
using Renilla Luciferase assay kit (Promega) on Moon-
light Luminometer (BD Biosciences) according to manu-
facturer’s instructions (2 s measurement delay followed by
10 s measurement time).
Ribopuromycilation assay
Cells were treatedwith indicated stresses for indicated times.
Five minutes prior to harvesting, puromycin was added to
cell media to a final concentration of 5 g/ml. Puromycin
was allowed to incorporate into de novo synthesized pro-
teome for 5min. Cells were washed 1XwithHBSS and com-
plete cell lysis was performed using 1% SDS, 5 mM MES
[pH 6.5]. Western blotting was performed on lysates using
anti-puromycin antibody to detect de novo protein synthesis
after cellular stress and anti-actin for normalization. Blots
were quantified, normalized to actin loading and plotted
relative to untreated control.
RESULTS
Generation of YB-1 cell lines
To analyze the extent to which YB-1 is required for cel-
lular functions of 5′-TOG-containing tiRNAs, we created
genetic nulls of YB-1 in human osteosarcoma (U2OS) and
breast cancer (MCF-7) cell lines using CRISPR/Cas9 tech-
nology (27,28). CRISPR design software (crisper.mit.edu)
was used to design gRNAs targeting the 1st exon of YB-1
within the coding sequence (Figure 1A).We obtained clonal
YB-1 knockout cell lines (YB-1) through limiting dilution
subcloning and screening by immunofluorescence. Knock-
outs were confirmed by western blotting using four differ-
ent polyclonal YB-1 antibodies (Figure 1B) raised to differ-
ent regions of the protein (Supplementary Figure S1A). In
theseYB-1 cells, we askedwhether SG components, trans-
lation initiation factors, general RNA binding proteins or
DACH1, the inhibitor of YB-1 (29), were altered by YB-
1 deletion (Figure 1B). We found no YB-1 dependent dif-
ference in the levels of any interrogated protein. This is in
contrast to recently published data by the Sorenson lab,
which reported that siRNA mediated knockdown of YB-
1 leads to decreased levels of G3BP1, a key SG regulator
(30), thus inhibiting SG formation in response to arsenite or
H2O2 (22). To address whether this disparity is due to dif-
ferences between transient siRNA knockdown (their study)
and genetic CRISPR/Cas9 mediated knockout, we per-
formed siRNA knockdown of YB-1 to determine whether
G3BP1 levels were affected. Despite efficient knockdown
of YB-1, we failed to see any discernable difference in the
levels of G3BP1 or DACH1 (Figure 1C and D). Moreover,
CRISPR/Cas9-mediated targeting of YB-1 by three inde-
pendent guide RNAs did not affect G3BP1 levels or sodium
arsenite (SA)-induced SG formation in YB-1-depleted cells
(Supplementary Figure S2). We also confirmed that YB-1
was disrupted at the DNA level by sequencing PCR ampli-
cons using primerswithin the promoter and intron 1 (Figure
1A) in YB-1 cells. We determined that a single adenosine
insertion (256insA) caused a frameshift mutation, thereby
ablating full length YB-1 expression (Figure 1E).
Genetic Heterogeneity of YB-1
While analyzing the YB-1 cells, we also sequenced wild-
type U2OS and, surprisingly, we found heterogeneity at the
WTYB-1 locus. One allele inWTU2OS harbored the same
256insA frameshift mutation as did the YB-1 cells. Se-
quencing in both directions confirmed that this frameshift
occurred due to a single adenosine insertion at RNA nu-
cleotide position 256 (256insA) (Figure 2A). Furthermore,
PCR products were cloned and sequenced demonstrating
the existence of two different alleles of YB-1, including one
with a single nucleotide insertion (Supplementary Figure
S1B and C). This insertion creates an RNA that encodes
a hypothetical 8 kDa protein including the first 28 amino
acids of YB-1 and unique sequence downstream (Figure
2B). We extended our analysis to other common cancer
cell lines and were surprised to find that MCF-7, Jurkat
and DU145 cells are heterozygous for the 256insA muta-
tion, whereas HeLa-S cells are homozygous WT (Figure
2C, Supplementary Figure S1D–G). We hypothesized that
mRNA encoding this protein would be inefficiently trans-
lated, as the frameshift causes a premature termination
codon (PTC) upstream of six exon junctions, thereby mak-
ing it a target for nonsense-mediatedmRNAdecay (NMD).
To determine if this is true, we generated a series of re-
porter plasmids (Figure 2D) encoding YFP-tagged YB-1
cDNA [pEYFP-YB1(WT)], YFP-tagged YB-1 containing
full length introns 4 and 5 [pEYFP-YB1 (In4+5)] and this
same construct harboring the 256insA frameshift [pEYFP-
YB1(In4+5/256insA)]. We transfected these plasmids into
U2OS cells along with an empty pEYFP plasmid and ana-
lyzed the expression of each construct by Western blotting.
We confirmed that insertion of two introns does not alter
the expression of tagged YB-1 (Figure 2E, c.f. lane 3 and
4) by western blotting for both YB-1 and YFP. YFP-YB1
(In4+5/256insA) does not accumulate as either tagged YB-
1 constructs or free YFP (Figure 2E, lane 2). Only overex-
posed blots are we able to detect any protein produced by
this construct (Figure 2E, lane 5). It is likely that the re-
duced expression is due to NMD of the mRNA; however, it
is also possible that the 256insA protein is inherently unsta-
ble. Because gRNAs used to generate YB-1 knockout cells
overlapped with 256insA (Supplementary Figure S1B), the
mutated allele would not be targeted by gRNA:Cas9 com-
plexes (31). Following Cas9-mediated double strand break,
repair was completed by homologous recombination using
Nucleic Acids Research, 2016, Vol. 44, No. 14 6953
Figure 1. Creation of YB1 cells. (A) CRISPR/Cas9 mediated deletion of YB-1 utilizing guide RNA located within the YB-1’s 1st exon. Green line indi-
cates location of gRNA and red arrows denote primers used for sequencing. (B) Western blotting confirming the loss of YB-1 expression, while other stress
granule proteins, translation factors and general RNAbinding proteins are unaffected. Ribosomal proteins Rack1 andRPS23 serve as loading controls. (C)
siRNA-mediated knockdown of YB-1 confirms that G3BP1 levels are unaffected by depletion of YB-1. In addition, levels of Dach1 are unaltered. RPS23
serves as a loading control. (D) Quantification of relative change in levels of YB-1 and G3BP1 (siYB1/siCtrl) in response to RNAi mediated depletion
of YB-1 confirms no change in G3BP1 levels. Levels of each protein are normalized to RPS23 (* P-value =0.0039, n=3). (E) CRISPR/Cas9 mediated
deletion of YB-1 occurs by insertion of a single adenosine nucleotide at position 256 of the YB-1 gene. Homozygous insertion is highlighted in red.
256insA as a template, thereby converting cells to homozy-
gous 256insA (Figure 1E) and null for YB-1 protein as de-
termined by western blotting (Figure 1B).
YB-1 knockouts show decreased proliferative and cell survival
responses
YB-1 has multiple reported growth phenotypes (18,32);
therefore, we began our analysis of YB-1 cells by deter-
mining their growth rates relative to WT cells. We found
a significant difference in the growth rates of YB-1 ver-
sus WT cells. YB-1 U2OS cells consistently exhibit ∼25%
slower growth than WT cells (Figure 3A), and this growth
defect is enhanced under low serum (0.1%) conditions (Fig-
ure 3B and D). In addition, low serum causes YB-1 cells
to undergo dramatic morphological changes (Figure 3B, c.f.
2Bb and 2Bd), an effect that was not observed in serum-
starved WT cells (Figure 3B, c.f. 2Ba and 2Bc).
YB-1 promotes EMT in breast cancer cells as well
as metastatic tumor formation via mesenchymal-epithelial
transition (MET) in sarcomas (33). Given these functions,
and considering the apparent change in morphology seen
when growing cells in low serum, we asked whether YB-
1 cells have altered expression of EMT/MET-associated
factors. WT and YB-1 cells were grown in 10% or 0.1%
serum for 3 days and then immunoblotted for Twist1, Zeb1,
Snail1, the key transcription factors regulating both EMT
and MET (34,35), or for G3BP1, a key regulator of SG
formation. Under normal growth conditions (10% serum),
cells lacking YB-1 express reduced levels of Twist1 and
Snail1 relative to WT controls (Figure 3C, c.f. lane 1 and
3). Under starvation conditions (0.1% serum), cells lacking
YB-1 express more Twist1 than doWT controls (Figure 3C,
c.f. lane 2 and 4), a finding thatmay contribute to altered cell
morphology. In contrast, expression of Snail1 or G3BP1 is
not altered by YB-1 or serum conditions. Consistent with
elevated Twist1-induced expression, YB-1 cells grow ex-
tremely slowly under low serum conditions (Figure 3D).
Stress granule formation in YB-1 cells
We next compared the SG response inWT andYB-1 cells
treated with oxidative (sodium arsenite, 100 M) or en-
doplasmic reticulum (thapsagargin, 1 M) stress by mon-
itoring SG formation using multiple SG markers (eIF4G,
G3BP1 and TIAR) with immunofluorescence microscopy.
Overall, YB-1 is not required for SG formation triggered by
either sodium arsenite or thapsigargin (Figure 4). In dose
response experiments, YB-1 deletion slightly impaired SG
formation at low concentrations (75 M) of sodium arsen-
ite (a representative quantification is shown inFigure 4B; we
were not able to quantify this data across experiments as the
concentration at which 100% of cells formed SA-induced
SGswere slightly different in each condition). In response to
all tested concentrations of thapsigargin, YB-1 cells were
only able to form stress granules in ∼40% of cells indicat-
ing some defect in ER stress-mediated SG assembly (Fig-
ure 4C). These data demonstrates that YB-1 can promote
SG assembly in response to some types of stress, an effect
unrelated to reduced expression of G3BP1.
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Figure 2. Naturally occurring YB-1 mutations (A) Sequencing of YB-1 genomic locus reveals that U2OS cells are heterozygous for a single nucleotide
insertion (256insA) within the first exon. Point of insertion is highlighted in red. (B) 256insA leads to a frame shift mutation that results in a truncated
protein whose mRNA is likely degraded via the nonsense mediated decay pathway. Amino acids downstream of insertion, which diverge from YB-1
sequence, are highlighted in red. (C) U2OS, DU145 and MCF7 cells are all heterozygous for 256insA mutation, while HeLa-S cells are homozygous
wild-type. (D) Schematized YFP-YB1 reporters used to determine if 256insA protein accumulates in cells. (E) Western blotting of U2OS transfected with
YFP-YB1 reporters demonstrates that 256insA upstream of 2 endogenous introns severely attenuates accumulation of this protein 2 days post transfection.
YB-1 is required for 5′-tiRNAAla-mediated stress granule for-
mation
5′-TOG-containing 5′-tiRNAs (5′-tiRNAAla and 5′-
tiRNACys) promote the assembly of SGs in a phospho-
eIF2 independent manner (7). Previous work in our
lab suggested that YB-1 is a mediator of SG formation
in response to 5′-tiRNAAla (9), correlating with YB-1-
dependent translational repression. Using ourYB-1 cells,
we asked to what extent YB-1 is required for 5′-tiRNAAla-
mediated SG formation. We found that transfection of
5′-tiRNAAla induces SG assembly in WT but not YB-1
cells (Figure 5A), consistent with a role for YB-1 in
tiRNA-mediated translation repression and SG formation.
UV-crosslinking experiments indicate that YB-1 directly
binds to 4-thiouridine (4SU)-labeled 5′-tiRNAAla (12).
The YB-1 CSD is likely responsible for specific binding to
5′-TOG-bearing tiRNAs, although non-specific binding
through its oligomerization domain may also contribute to
this interaction. CSDs are evolutionary conserved nucleic
acid binding domains (13). The CSD of YB-1 is highly
similar to that of Lin28A and Lin28B (Figure 5B). In par-
ticular, a phenylalanine residue in Lin28A that is required
for binding to Let-7 pre-miRNAs is conserved in YB-1.
Modelling of the YB-1 CSD using solved crystal structures
of Lin28A suggested that a binding pocket formed by YB-1
Phe85 could coordinate nucleotides within the 5′-tiRNAAla
D-loop (Figure 5C). Therefore, we expressed and purified
recombinant truncated YB-1 (amino acids 1-129) with
WT CSD or harbouring a Phe to Ala mutation (F85A),
both lacking the oligomerization domain (Supplemen-
tary Figure S1A). EMSAs demonstrate that the Phe85
residue is absolutely required for specific RNA binding to
5′-tiRNAAla (Figure 5D).
To determine whether F85 contributes to YB-1 bind-
ing to tiRNAs in cells, we reconstituted the YB-1 U2OS
cells with YFP-YB1 (WT), YFP-YB1 (F85A) or free YFP
(Figure 5E), and obtained clonally selected reconstituted
cell lines. YFP-YB1 (WT) localized to SGs upon oxidative
stress (Figure 5F) and to P-bodies under basal conditions
(Figure 5G) in accordance with previously reported activi-
ties of endogenous YB-1 (36). Remarkably, the F85A mu-
tation dramatically re-localized YFP-YB1 to the nucleus
(Figure 5H and I), and YFP-YB1(F85A) only weakly as-
sociated with SGs in response to oxidative stress (Figure
5H). The major fraction of YFP-YB1(F85A) was nuclear
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Figure 3. Deletion of YB-1 affects cell growth and survival. (A) YB1 U2OS cells grow at an impaired rate as compared to parental U2OS cells. Cell
growth was monitored by cell counting over 4 days. Data represent three independent experiments. Error bars are ± standard error. (B) Serum starvation
of YB1 U2OS cells causes dramatic morphological changes not seen in parental U2OS cells. Cells grown in 10% (Ba and Bb) or 0.1% (Bc and Bd) serum
for 3 days are shown (phase-contrast images). (C) Levels of EMT/MET-associated factors (Snail1, Twist1) are changed under optimal conditions and in
response to serum starvation in YB1 U2OS cells. G3BP1 levels remain unaltered in response to serum starvation. TIAR serves as a loading control. (D)
YB1 U2OS cells growth/survival is impaired in response to serum starvation. Indicated cells were grown in 10% or 0.1% serum for 7 days and manually
counted. Data represent three independent experiments. Error bars are ± standard error.
Figure 4. YB-1 depletion does not inhibit sodium arsenite-induced SG formation. (A) YB1 U2OS cells are competent to form SGs in response to 100
M sodium arsenite or 1 MThapsigargin (1 h). SG formation was monitored by immunofluorescence of classic SG markers, eIF4G, G3BP1 and TIAR.
(B) A representative example of quantification of SG formation following a titration of sodium arsenite for 1 h revealing a slight delay in SG assembly in
YB1 U2OS cells. Immunofluorescence was used to visualize SG markers (eIF4G, G3BP1 and TIAR). Cells were scored as SG positive if they contained
at least 3 foci co-localizing all three markers. (C) Quantification of SG formation in response to a titration of thapsigargin (1 h) shows an impaired ability
to form SGs in a subset of cells. Cells were imaged by indirect immunofluorescence was used to visualize SG markers (eIF4G, G3BP1 and TIAR). Cells
were scored as SG-positive if they contained at least 3 foci co-localizing all three markers (* P-value <0.05, n=3).
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Figure 5. YB-1 is required for 5′-tiRNAAla-induces stress granule formation. (A) Quantification of SG formation in response to 5′-tiRNAAla demonstrates
a blockage in SG formation. Cells were transfected with 100 pmol of 5′-tiRNAAla for 6 h and SG were visualized by indirect immunofluorescence with
SG markers (eIF4G, G3BP1 and TIAR). (B) Conservation of cold shock domain (CSD) of YB-1, Lin28A and Lin28B demonstrates conservation of the
key phenylalanine residue required for Lin28:let-7 microRNA interaction (49). (C) Modeling of YB-1 CSD based on the Lin28 crystal structure reveals
a binding pocket utilizing Phe85 (yellow) that could bind 5′-tiRNAAla (orange). (D) Mutation of Phe85 to Alanine (F85A) prevents binding of YB-
1 to 5′-tiRNAAla in an EMSA. Recombinant YB-1 (1–129) was expressed and purified from E. coli. Titration (0–500 pmol) of the recombinant YB-1
protein was used to shift 0.25 pmol of [32P]-radiolabeled 5′-tiRNAAla. (E) Generation of YB-1 U2OS cells reconstituted with YFP, YFP-YB1 (WT)
or YFP-YB1 (F85A). Expression of YFP tagged constructs were analyzed by GFP and YB-1 antibodies. * indicated breakdown products from YFP
tagged YB-1 constructs detected in GFP Western blotting. Reconstitution did not alter G3BP1 expression. Rack1 and RPS23 serve as loading controls.
(F) YFP-YB1 (WT) localizes to SG following oxidative stress induced by 100 M sodium arsenite treatment for 1 h as indicated by co-localization with
eIF4G and G3BP1. (G) YFP-YB1 (WT) localizes to P-bodies under basal conditions as indicated by colocalization with DDX6 (rck/p54). (H) YFP-YB1
(F85A) weakly localizes to stress granules in response to oxidative stress induced by sodium arsenite (100 M for 1 h). (I) YFP-YB1(F85A) predominantly
localizes to the nucleus. Co-staining with Fibrillarin demonstrates high concentrations of YFP-YB1(F85A) within the nucleolus. Co-staining with Hedls
demonstrates that YFP-YB1(F85A) fails to localise to P-bodies (arrowhead). (J) Reconstitution of YB1 U2OS cells with YFP-YB1(WT) rescues SG
formation in response to 5′-tiRNAAla, while reconstitution with YFP or YFP-YB1(F85A) fails to rescue. Stress granule formation was induced as in Figure
5A.
with particularly high concentrations in the nucleolus as de-
termined by co-staining with Fibrillarin (Figure 5I). YFP-
YB1(F85A) also failed to localized to P-bodies under basal
conditions as monitored by co-staining with Hedls (Fig-
ure 5I). YFP-YB1 (WT) fully restored tiRNAAla’s ability to
trigger SG formation; whereas reconstitutionwith free YFP
orYFP-YB1(F85A) failed to rescue SGs (Figure 5J). There-
fore, YB-1 is required for 5′-tiRNAAla-induced SG forma-
tion and its binding to 5′-tiRNAAla is required for this func-
tion.
YB-1 is not required for 5′-tiRNAAla-mediated translation re-
pression
We next sought to determine if YB-1 is required for inhibi-
tion of translation. We previously showed that 5′-tiRNAAla
inhibits translation initiation by displacing eIF4F from the
5′ mRNA cap (9). To determine if YB-1 is required for dis-
placement of eIF4F from m7GTP, we purified eIF4F and
associated proteins, including YB-1, on m7GTP-agarose.
Pre-formed complexes were then challenged with control
RNA, inactive 5′-tiRNAMet or active 5′-tiRNAAla. Despite
an inability to form SGs in response to 5′-tiRNAAla, eIF4F
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complexes from YB-1 cells are displaced from m7GTP
cap as efficiently as eIF4F complexes fromWT cells (Figure
6A). To extend this analysis, we prepared in vitro translation
lysates from WT or YB-1 cells and analyzed the ability
of 5′-tiRNAAla to inhibit the translation of an mRNA lu-
ciferase reporter in these systems (37). Translation of the re-
porter mRNAwas equally repressed in both lysates (Figure
6B), providing further evidence that YB-1 is not required
for inhibition of translation in response to 5′-tiRNAAla, de-
spite being required for SG formation (Figure 5A). We have
previously shown that transfection of 5′-tiRNAAla modestly
inhibits translation in U2OS cells. To determine if YB-1
contributes to this effect, we transfected 5′-tiRNAAla into
WT or YB1 U2OS cells and quantified incorporation of
puromycin into the proteome following a 5-min pulse. In
agreement with in vitro data, ablation of YB-1 inU2OS cells
did not significantly affect 5′-tiRNAAla-mediated transla-
tional repression (Figure 6C and D). In cells, it is possible
that YB-1 protects tiRNAs from exonucleolytic degrada-
tion; however, as loss of YB-1 does not alter the function-
ality of 5′-tiRNAAla, it is unlikely that it alters its stability.
Further, G-quadruplex-like structures, like those found at
the 5′ end of 5′-tiRNAAla, are intrinsically insensitive to nu-
cleolytic attack, as are 2′–3′ cyclic phosphates found at the
3′ end of 5′-tiRNAAla.
DISCUSSION
tRNA cleavage is an evolutionarily conserved phenomenon
serving various functions in different organisms (38–40).
In mammalian cells, tRNA cleavage is involved in a cellu-
lar stress response program that enhances cell survival un-
der stress. We showed the ribonuclease ANG is activated
to produce tiRNAs that act at the post-transcriptional level
to re-program cellular translation (8). Selected 5′-tiRNAs
(5′-tiRNAAla and 5′-tiRNACys) containing 5′-TOG motifs
and assembling G-quadruplex-like structures are potent in-
hibitors of translation (12). On the molecular level, these
5′-TOG-tiRNAs interfere with assembly of the cap-binding
eIF4F complex to inhibit translation initiation (9). On the
cellular level, and as a consequence of translation repres-
sion, tiRNAs promote the assembly of cytoprotective SGs
(7). Biochemical approaches identified the known transla-
tional silencer YB-1 as a direct partner of 5′-TOG tiRNAs.
Here we demonstrate that YB-1 is required for the tiRNA-
induced assembly of SGs, but not for tiRNA-mediated
translation inhibition.
YB-1 has long been recognized as a potential oncogene
(18,32). YB-1 is overexpressed in multiple cancer types and
its increased expression is associated with increased inva-
siveness (17). This function has been partially attributed to
YB-1’s ability to promote the translation of EMT/MET-
associated factors, such as Snail1 and Twist1 (20,21), while
simultaneously inhibiting the translation of other cellu-
lar mRNAs (41). Such YB-1-mediated reprogramming of
cellular translation contributes to cancer cell survival and
transformation. In the Evdokimova et al. study (21), overex-
pression of ectopic YB-1 led to increased Snail1 and Twist1
expression with consequent transformation of non-invasive
breast cancer cells into malignant carcinomas. Here, in the
reciprocal experiment, we demonstrate thatCRISPR/Cas9-
based ablation of YB-1 leads to reduced expression of
Snail1 and Twist1 proteins (Figure 3C, c.f. lanes 1 and
3), supporting YB-1’s proposed role in EMT. Further, this
correlates with diminished proliferative capacity of YB-1
U2OS cells (Figure 3A) and decreased survival in response
to serum-starvation (Figure 3D). These data further high-
light the pro-proliferative effects of YB-1 that support tu-
mor growth and survival.
While the role of YB-1 in EMT and epithelial malignan-
cies is well established, recent reports also suggest that YB-
1 drives metastasis in sarcomas, malignancies of mesenchy-
mal origin. This role may be attributed to YB-1 functions in
the regulation of Snail1/Twist/ZEB1 transcription factors,
the factors that are implicated in both EMT of epithelial
cancers and MET of sarcomas (34). Moreover, two recent
reports from the Sorensen lab (22,33) demonstrated that
YB-1 overexpression positively correlates with carcinoma
progression and metastatic dissemination as well as its el-
evation in high-risk sarcomas and association with poor
outcome. Both reports suggest that YB-1 promotes tumor
progression by translational activation of its mRNA tar-
gets, namely HIF1α and/or G3BP1 transcripts. As a re-
sult of YB-1 dependent HIF1 up-regulation cancer cells
adapt to hypoxia, a stress condition that plays a dominant
role in tumor invasion and metastasis. Similarly, transla-
tional activation of G3BP1 expression also promotes adap-
tation to cellular stresses. Samasekharan et al. reported that
YB-1 promotes tumor progression viaG3BP1-mediated SG
formation (22). While the role of G3BP1 in the promo-
tion of SGs is well documented (42,43), our data suggest
that YB-1 regulates SG formation in a more complex and
stress-specific manner. In contrast to Samasekharan et al.
(22), our results do not support a direct role for YB-1
in the regulation of G3BP1 expression since siRNA- and
CRISPR/Cas9-mediatedYB-1 depletion does not affect ex-
pression of G3BP1. This difference may be attributed to
the known heterogeneity of U2OS cells that results from
defects in the maintenance of cell ploidy (44). We do ob-
serve that YB-1 depletion modestly delays sodium arsenite-
induced SG assembly (Figure 4B) as reported in their study.
Interestingly, YB-1 depletion strongly affects thapsigargin-
and dominantly down-regulates tiRNA- mediated SG for-
mation (Figures 4C and 5).
The prevalence of a single nucleotide insertion in the first
exon of YB-1 is striking. Four of the five cell lines tested
were found to possess this heterozygous mutation. This
frameshift mutation (256insA) creates a PTC in the second
exon. Translation of this mRNA would lead to an 8-kDa
protein sharing only the first 27 amino acids with YB-1.
Our data suggest that this protein does not accumulate to
the same extent as endogenous YB-1. The mRNA is likely
degraded by the nonsense mediated mRNA decay path-
way (45) (due to the presence of six exon junctions down-
stream of the PTC), resulting in mRNA degradation and
minimal production of this truncated protein. NMD func-
tions to clear the cell of mRNAs that could code for toxic
non-functional C-terminally truncated proteins. However,
there are several instances of ‘NMD escape’ in which NMD
targets are not efficiently cleared thereby allowing for the
synthesis of toxic protein products. Our data show that the
256insA mutation severely reduces the levels of a reporter
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Figure 6. YB-1 is dispensable for 5′-tiRNAAla-induced eIF4F disassembly and translation inhibition (A) Genetic ablation of YB-1 does not affect ability of
5′-tiRNAAla to displace eIF4F fromm7GTP. A total of 100 pmol of the indicated RNAwas added to eIF4F preformed onto m7GTP-agarose. 5′-tiRNAAla
was able to displace eIF4G and a portion of eIF4E in bothWT orYB-1 Lysates (c.f. lane 5 and 10). (B) In vitro translation assays utilizing cell lysates from
WT U2OS or YB-1 U2OS. Efficiency of uncapped Renilla luciferase mRNA translation was monitored by luminescence. Addition of 5′-tiRNAAla to in
vitro translation lysate inhibited the translation of the luciferase mRNA to the similar extents in both WT and YB-1 U2OS lysates (*- p-value =0.0004,
n=4). (C) 5′-tiRNAAla represses global translation in both WT and YB1 U2OS cells. Cells were transfected with 100 pmol of indicated RNAs for 6 h.
Cells were pulsed with puromycin to a final concentration of 5 g/ml for 5 min. Cells were lysed in 1% SDS, 5 mM MES [pH 6.5] to ensure translation
does not continue during lysis. Relative translation efficiency was analyzed by western blotting for puromycin incorporated into the proteome. Ponceau
staining and actin levels serve as a loading control. Treatment of cells with 100 M sodium arsenite for 1 h previous to puromycin labelling serves as a
control for inhibition of translation and specificity of puromycin antibody. (D) Quantification of relative incorporation of puromycin into protein (n = 3)
normalized to actin. * is P < 0.003. ** is P < 0.0007.
Figure 7. Model of YB-1’s involvement in tiRNA-mediated stress response pathway. (A) Actively translating mRNA is circularized through the interaction
of eIF4F (orange), PABP (blue), translation termination factors eRF1/eRF3 (pink). (B) During stress, tRNAs are cleaved by ANG creating 5′-tiRNAs
which displace eIF4F from m7GTP cap of mRNA (C), thereby inhibiting translation initiation. (D) YB-1 (green-orange) acts to package inactive mRNPs,
inhibited through the action of 5′-tiRNAs, into SGs.
harbouring the mutation (Figure 2). However, some protein
product remains and therefore, it is possible that it may have
some unidentified cellular effect.
It is unclear how the loss of one YB-1 allele will affect
cellular function. YB-1 autoregulates its own expression by
binding to the 5′UTR ofYB-1mRNA and inhibiting trans-
lation (46). Therefore, a 50% reduction ofYB-1mRNAmay
affect levels of YB-1 protein through inhibition of its own
mRNA translation. The prevalence of the 256insA muta-
tion in commonly grown cancer lines implies that this al-
teration confers a growth or survival advantage. Given the
documented roles of YB-1 and ANG in carcinogenesis, it
is tempting to speculate that this mutation reduces the ex-
pression ofYB-1 and/orYB-1:tiRNA complexes. Such dys-
regulation may affect the ability of tiRNAs and or YB-1 to
re-program cellular translation/formation of SGs and pre-
dispose cells toward a cancerous state.
ANG, the ribonuclease responsible for 5′-tiRNA biogen-
esis, is also upregulated in many cancers. The effects of
YB-1 on mRNA translation overlap significantly with ef-
fects of tiRNAs on translation. Both YB-1 and 5′-TOG-
tiRNAs are repressors of cap-dependent translation (18). It
has been suggested that YB-1 modulates translation initia-
tion by preventing association of eIF4G with the m7GTP
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mRNA cap (16,47) and/or by stabilization of eIF4F on
the m7GTP cap (15). Similarly, 5′-TOG-containing tiRNAs
displace eIF4G/E from the m7GTP cap. We previously re-
ported that YB-1 interacts with 5′-TOG-containing tiR-
NAs in cell lysates (12). Our EMSA analysis using purified
YB-1 and synthetic tiRNAs confirmed these direct interac-
tions (Figure 5B–D). Moreover, we show that a conserved
Phe85 residue in the CSD of YB-1 is responsible for the in-
teraction and a Phe-85-Ala mutation completely abolishes
binding of YB-1 to tiRNAs (Figure 5, and not shown). As
tiRNAs interact with YB-1, and siRNA-based depletion
of YB-1 decreases the ability of tiRNAs to promote SGs,
we initially hypothesized that YB-1:tiRNA complexes may
directly inhibit translation initiation. This hypothesis has
been refuted by three observations: (i) genetic ablation of
YB-1 in U2OS cells does not alter the ability of 5′-tiRNAs
to displace eIF4F components from the m7GTP cap, (ii) an
in vitro translation system using cell lysates prepared from
WT and YB-1 U2OS cells reveals that 5′-tiRNAAla in-
hibits mRNA translation of a luciferase reporter in a YB-1
independent manner, and (iii) global translation is reduced
in response to 5′-tiRNAAla in YB-1 U2OS cells.
YB-1 is required for SG formation in response to tiR-
NAs. Following inhibition of translation initiation, stalled
48S pre-initiation complexes condense into SGs (48). This
occurs through a two-step process. Following translation
inhibition, polysomes disassemble leading to a sudden in-
flux of untranslated mRNPs. At this stage, protein syn-
thesis has ceased, but discrete SGs have not yet assem-
bled. The 2nd step of SG formation involves the actions
of aggregation-prone proteins possessing low complexity
motifs (e.g. G3BP1/2, TIA1/R, etc.) that support a liquid
phase translation required for SG assembly. As this step of
SG formation is impaired by the loss of YB-1 in response
to 5′-tiRNAAla (Figure 5), we propose that YB-1 works as
an ‘RNA chaperone’ to help packaging mRNA inhibited
by tiRNAs into SGs. Components of eIF4F are still dis-
placed from m7GTP and translation is inhibited in the ab-
sence ofYB-1, but nakedmRNA is unable to be packed into
SGs. An appealing scenario is that tiRNA binding to the
YB-1 CSD promotes a conformational change that allows
for increased non-specific RNA binding affinity or multi-
merization through the OMD. In agreement with this hy-
pothesis, reconstitution of YB1 U2OS cells with wild-
type YB-1, but not with F85A YB-1, rescues 5′-tiRNAAla
mediated SG formation. Because 5′-tiRNAAla triggers SG
formation through an eIF2 phosphorylation independent
mechanism, other SG nucleating proteins (e.g. G3BP1) are
not activated and therefore cannot compensate for loss of
YB-1.
We propose the following model for 5’-tiRNAAla func-
tion during the stress response. Under normal growth con-
ditions, polysomes form a closed-loop translation complex
mediated by interactionwith eIF4G and PABP (Figure 7A).
In response to stress, tRNAs are cleaved within the anti-
codon loop by ANG, creating 5′- and 3′-tiRNAs, of which a
subset of 5′-TOG-containing tiRNAs have bioactivity (Fig-
ure 7B). 5′TOG-containing tiRNAs facilitate the displace-
ment of eIF4F from the mRNA cap, disrupting translation
initiation (Figure 7C). Stalled translation complexes con-
dense into SGs mediated by 5′-tiRNAAla bound to the CSD
of YB-1 (Figure 7D). An unresolved question is the mecha-
nism bywhich tiRNAAla promotes eIF4F disassembly to re-
press translation. If the YB-1:tiRNA mRNP complex does
not directly act on eIF4F, does 5′tiRNAAla assemble into
other complexes that promote this activity? Alternatively,
are there additional components of the YB-1:tiRNA com-
plex yet to be discovered? Future investigations will eluci-
date the answer to this question.
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